Jacobson Pharma Corporation Limited (“Jacobson Pharma” or “the Group”; Stock Code: 2633.HK), a leading company engaged in the research, development,…
Browsing: Jacobson Pharma
Delivers Solid Performance Amidst Market Challenges; Revenue Increases +6.3%; Maintains Full-Year Dividend Per Share of HK4.5 Cents Jacobson Pharma Corporation…
HONG KONG, Nov 12, 2019 – (ACN Newswire) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company…
Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in research, development, production,…
Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company engaging in the research, development,…
Profit from Operations Leapt by 40.7% to HK$158.6 Million; Declares Interim Dividend of HK1.5 cents per share; Growth Strategies to…
HONG KONG — Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company engaged in…